Durgical
EN
Open the app

Topical antibacterials

Antibiotics applied to the skin for superficial infections such as impetigo, and to protect burns. Short courses limit resistance.

Updated

What they are

Antibacterials made to act on the skin surface: mupirocin for impetigo and for nasal carriage of Staphylococcus aureus, fusidic acid for superficial skin infections, retapamulin and ozenoxacin for impetigo, and silver sulfadiazine for burns. Deeper or spreading infections (cellulitis, abscess) need systemic antibiotics instead.

Mechanism of action

The agents differ: mupirocin blocks isoleucyl-tRNA synthetase, retapamulin binds a unique site on the 50S ribosomal subunit, and silver sulfadiazine releases silver that damages the bacterial membrane, wall and DNA. Applied locally they reach high concentrations at the infected surface with little systemic exposure.

Target: Bacterial protein synthesis (isoleucyl-tRNA synthetase, ribosome) or bacterial membrane and DNA (silver)

Drugs in this class

Others in the class

  • fusidic acid
  • retapamulin
  • ozenoxacin
  • bacitracin
  • mafenide

Test yourself

Think of the answer, then tap the question to see it.

Which enzyme does mupirocin inhibit?

Bacterial isoleucyl-tRNA synthetase, so isoleucine cannot be loaded onto its tRNA and protein synthesis stops.

Why is silver sulfadiazine avoided in newborns in their first two months?

It is a sulfonamide and can raise the risk of kernicterus.

When is a topical antibiotic not enough for a skin infection?

When the infection is deep or spreading (cellulitis, abscess), widespread, or accompanied by fever: systemic antibiotics are needed.

Add to my cards (3)

More Pharmacology questions →

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - MUPIROCIN ointment (DailyMed (U.S. National Library of Medicine), 2026); DailyMed - SILVER SULFADIAZINE cream (DailyMed (U.S. National Library of Medicine), 2026); Global guidelines for the prevention of surgical site infection (World Health Organization, 2018).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.